肿瘤浸润淋巴细胞与肿瘤出芽在早期口腔舌癌中的预后作用
该回顾性研究分析了62例仅接受原发手术的早期口腔舌鳞状细胞癌标本,采用免疫组化检测CD4+、CD8+、FoxP3+、CD45RO+ T细胞及CD163+巨噬细胞。多因素分析显示肿瘤实质内高密度CD163+巨噬细胞是区域控制和无病生存的最差预后因素,且其高密度联合中/高级别出芽评分提示区域控制预后不良。
要点
- 肿瘤实质内高密度CD163+巨噬细胞是区域控制和无病生存的不良预后因素。
- CD163+巨噬细胞高密度联合中或高级别出芽评分可进一步分层区域控制预后。
- 日常临床中识别TIL亚型有助于制定个体化治疗策略。
核心结论
- 肿瘤实质内高密度CD163+巨噬细胞是早期口腔舌鳞癌区域控制和无病生存的风险因素。
- CD163+巨噬细胞高密度联合中或高级别出芽评分可作为区域控制的额外分层因素。
- 不同TIL亚型在口腔舌鳞癌早期和晚期可能通过不同机制发挥作用。
研究设计与样本
- 回顾性研究,纳入62例仅接受原发手术治疗的早期口腔舌鳞状细胞癌患者。
- 采用免疫组化检测CD4+、CD8+、FoxP3+、CD45RO+ T细胞及CD163+巨噬细胞。
- 在肿瘤实质和间质两个区域及浸润边缘外周间质中计数各TIL亚型的最高数量。
主要发现
- 多因素分析显示肿瘤实质内高密度CD163+巨噬细胞是区域控制和无病生存的最差预后因素。
- log-rank检验显示肿瘤实质内高密度CD163+巨噬细胞联合中或高级别出芽评分患者区域控制预后不良。
临床怎么用
- 日常临床中可识别TIL亚型以辅助判断早期口腔舌鳞癌预后并制定个体化治疗策略。
- 对肿瘤实质内CD163+巨噬细胞高密度且出芽评分中或高级别者,应加强区域控制评估。
局限性
- 本研究为回顾性研究,证据等级为Level 4。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Occult lymph metastasis is an important prognosticator for the treatment of early oral tongue squamous cell carcinoma (SCC). The objective of this study was to evaluate the prognostic significance of tumor-infiltrating lymphocytes (TILs) in early oral tongue SCC. The combination of the TIL subtype and intermediate- or high-grade budding scores was investigated as a prognostic marker for occult neck metastases. STUDY DESIGN: Retrospective study. METHODS: Specimens from 62 patients with early oral tongue SCC treated with only primary surgery were analyzed by immunohistochemistry for CD4+, CD8+, FoxP3+, and CD45RO+ T cells and CD163+ macrophages. The highest number of each TIL subtype was counted in two areas of parenchyma and stroma in the tumor (Tumor) and peripheral stroma of the invasion margin. RESULTS: Based on multivariate analysis, a high density of Tumor CD163+ macrophages served as the poorest prognostic factor for regional control (RC) and disease-free survival (DFS). Patients with both a high density of Tumor CD163+ macrophages and an intermediate- or a high-grade budding score had a poor prognosis for RC according to the log-rank test. CONCLUSIONS: In summary, each TIL subtype may use different mechanisms during early and advanced stages of oral tongue SCC. A high density of Tumor CD163+ macrophages was determined to be a risk factor for RC and DFS as well as an additional stratification factor for RC in patients with intermediate- or high-grade budding scores. Therefore, identifying TIL subtypes in daily clinical practice can help determine a more successful and individualized therapeutic approach for early oral tongue SCC. LEVEL OF EVIDENCE: Step 4 (Level 4) Laryngoscope, 131:2512-2518, 2021.
引用
- Hori Y, Kubota A, Yokose T, et al. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma. Laryngoscope. 2021. PMID: 33955550. doi:10.1002/lary.29589
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。